Otsuka America Pharmaceuticals

Zeno helped Otsuka America, a privately–held division of a major Japanese conglomerate, establish a reputation in the U.S. as an innovative developer of new therapies the CNS and GI categories exclusively. With no brands on the market and no products in late clinical trials, Zeno worked with Otsuka to develop non–product–oriented storylines to provide a catalyst for media interest, focusing on the Japanese parentage, proprietary methodology, and key executives with unique stories, non–branded support for patient groups and community efforts. Otsuka gained signficantly in “share of mind” earned media coverage as compared to its leading (Japanese) rivals.

Health

Work In Action